Skip to content

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

The Use of AR / VR in Patients Presenting to the ED With Renal Colic

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07070401
Enrollment
92
Registered
2025-07-17
Start date
2025-04-01
Completion date
2026-03-31
Last updated
2025-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Stones, Urolithiasis, Hypocitraturia, Renal Colic

Keywords

Renal Colic, Nephrolithiasis, Urolithiasis, Emergency Department, Pain Management, Virtual Reality, Augmented Reality, Audiovisual Stimulation, Patient Anxiety

Brief summary

Utilization of VR / AR Calming as an adjunct to pharmacologic pain management for Renal Colic in Emergency Department Patients

Detailed description

This study will randomize ED patients presenting for presumed renal colic to either standard pharmacologic pain management alone, or pharmacologic management plus use of an adjunct Virtual / Augmented reality calming application using an off-the-shelf VR/AR Headset.

Interventions

DEVICECommercial AR/VR Headset with Calming App

Commercial AR/VR Headset with Calming App in addition to Pharmacologic Standard of Care

OTHERPharmacologic Standard of Care Alone

Pharmacologic Standard of Care Alone

Sponsors

Community Medical Center, Toms River, NJ
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial between Standard of Care vs Standard of Care + Adjunct AR Calming

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient self-reported history of nephrolithiasis * Subjective history suggesting that current presentation is similar to past presentations of nephrolithiasis (character, quality, location, intensity of pain; previous surgical intervention or lithotripsy) * Patients with self-reported moderate to severe pain on the visual pain scale determined as greater than 5/10 * Normal vital signs (afebrile) * Agreeable to informed consent as dictated by IRB and local practice * No contraindications to standard therapy (ie fluids, NSAIDs, opioids, etc.) * Compliance with the virtual reality treatment * Keeps the headset on for the duration of the experience * Understands the instructions

Exclusion criteria

* Age \< 18 years * Pregnant * Individuals with chronic pain conditions such as fibromyalgia (chronic pain may confound results, as patients may have higher than baseline pain levels affecting their response to medications) * Individuals with severe anxiety or claustrophobia * Individuals with severe motion sickness or previous episodes of motion sickness due to VR (those who may not react well to the VR experience) * Individuals with GFR\<60 or previous documented diagnosis of CKD as they may not be suitable candidate for traditional analgesia * Individuals with previous opioid dependence * Requirement of immediate surgery (obstructing calculi with concomitant urinary tract infection) * Patients with diagnoses meeting admission criteria (sepsis, MI) * Audio/visual impairment (unable to appreciate stimuli provided by the headset) * Patients administered opiates as the first line pain control medication will not be included in final data collection, as opioid administration may result in difficulty consenting and understanding the study protocol / design

Design outcomes

Primary

MeasureTime frameDescription
60 Minute Pain Level60 minutesPain Level Change 60 minutes after enrollment, utilizing a 0-10 subjective score

Secondary

MeasureTime frameDescription
30 Minute Pain Level30 minutesPain Level 30 minutes after enrollment, utilizing a 0-10 subjective score
30 Minute Heart Rate30 minutesChange in Heart Rate 30 minutes after enrollment
30 Minute Blood Pressure30 minutesSystolic and Diastolic Blood Pressures 30 minutes after enrollment
60 Minute Heart Rate60 MinutesChange in Heart Rate 60 minutes after enrollment
Rescue Analgesia Use4 hoursRequirement for Rescue Analgesia
Rescue Intervention24 HoursRequirement of Specialty Urologic Procedural Intervention for Pain Management (All Cause)
60 Minute Blood Pressure60 minutesSystolic and Diastolic Blood Pressures 60 minutes after enrollment

Other

MeasureTime frameDescription
Visual Analog Scale for Anxiety60 minutesAnxiety, as measured on a 10 cm line, with 0 being no anxiety, and 10 being worst anxiety patient has experienced, caused by AR Headset, to be measured in the AR Arm only
Subjective AR Experience60 minutesLikert Scale Response on if patient would use AR headset again, in AR arm only: 1 - Would Never Use Again; 2 - Would Consider Using Again; 3 - Neutral; 4 - Would Definitely Use Again if Offered; 5 - Would Ask to Use It Even if Not Offered

Countries

United States

Contacts

Primary ContactGreg Neyman, MD
GregoryMD.Neyman@rwjbh.org732.557.3242

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026